Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Unique cyanide adduct in human serum albumin: potential as a surrogate exposure marker.

Fasco MJ, Stack RF, Lu S, Hauer CR 3rd, Schneider E, Dailey M, Aldous KM.

Chem Res Toxicol. 2011 Apr 18;24(4):505-14. doi: 10.1021/tx100344e. Epub 2011 Mar 18.

2.

Investigations of the posttranslational mechanism of arsenite-mediated downregulation of human cytochrome P4501A1 levels: the role of heme oxygenase-1.

Bessette EE, Fasco MJ, Pentecost BT, Reilly A, Kaminsky LS.

J Biochem Mol Toxicol. 2009 May-Jun;23(3):222-32. doi: 10.1002/jbt.20283.

PMID:
19526463
3.

Cyanide adducts with human plasma proteins: albumin as a potential exposure surrogate.

Fasco MJ, Hauer CR III, Stack RF, O'hehir C, Barr JR, Eadon GA.

Chem Res Toxicol. 2007 Apr;20(4):677-84. Epub 2007 Mar 21.

PMID:
17373827
4.

Plasma and cellular markers of 3'-azido-3'-dideoxythymidine (AZT) metabolism as indicators of DNA damage in cord blood mononuclear cells from infants receiving prepartum NRTIs.

Meng Q, Olivero OA, Fasco MJ, Bellisario R, Kaminsky L, Pass KA, Wade NA, Abrams EJ, Nesel CJ, Ness RB, Bigbee WL, O'Neill JP, Walker DM, Poirier MC, Walker VE.

Environ Mol Mutagen. 2007 Apr-May;48(3-4):307-21.

PMID:
17358024
6.

Gene regulation in an MCF-7 cell line that naturally expresses an estrogen receptor unable to directly bind DNA.

Pentecost BT, Bradley LM, Gierthy JF, Ding Y, Fasco MJ.

Mol Cell Endocrinol. 2005 Jun 30;238(1-2):9-25.

PMID:
15913882
7.

Upstream regions of the estrogen receptor alpha proximal promoter transcript regulate ER protein expression through a translational mechanism.

Pentecost BT, Song R, Luo M, DePasquale JA, Fasco MJ.

Mol Cell Endocrinol. 2005 Jan 14;229(1-2):83-94.

PMID:
15607532
8.

Mechanisms of arsenite-mediated decreases in benzo[k]fluoranthene-induced human cytochrome P4501A1 levels in HepG2 cells.

Bessette EE, Fasco MJ, Pentecost BT, Kaminsky LS.

Drug Metab Dispos. 2005 Mar;33(3):312-20. Epub 2004 Dec 2.

PMID:
15576448
9.

Differential action of polycyclic aromatic hydrocarbons on endogenous estrogen-responsive genes and on a transfected estrogen-responsive reporter in MCF-7 cells.

Gozgit JM, Nestor KM, Fasco MJ, Pentecost BT, Arcaro KF.

Toxicol Appl Pharmacol. 2004 Apr 1;196(1):58-67.

PMID:
15050408
10.

Phase I and II carcinogen metabolism gene expression in human lung tissue and tumors.

Spivack SD, Hurteau GJ, Fasco MJ, Kaminsky LS.

Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):6002-11.

11.

Phenotypic changes in MCF-7 cells during prolonged exposure to tamoxifen.

Fasco MJ, Amin A, Pentecost BT, Yang Y, Gierthy JF.

Mol Cell Endocrinol. 2003 Aug 29;206(1-2):33-47.

PMID:
12943988
12.

Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue.

Fasco MJ, Hurteau GJ, Spivack SD.

Mol Cell Endocrinol. 2002 Feb 25;188(1-2):125-40.

PMID:
11911952
13.

Polycyclic aromatic hydrocarbon/metal mixtures: effect on PAH induction of CYP1A1 in human HEPG2 cells.

Vakharia DD, Liu N, Pause R, Fasco M, Bessette E, Zhang QY, Kaminsky LS.

Drug Metab Dispos. 2001 Jul;29(7):999-1006.

PMID:
11408366
14.

Expression of an estrogen receptor alpha variant protein in cell lines and tumors.

Fasco MJ, Keyomarsi K, Arcaro KF, Gierthy JF.

Mol Cell Endocrinol. 2000 Aug 30;166(2):156-69.

PMID:
11203301
15.

Effect of metals on polycyclic aromatic hydrocarbon induction of CYP1A1 and CYP1A2 in human hepatocyte cultures.

Vakharia DD, Liu N, Pause R, Fasco M, Bessette E, Zhang QY, Kaminsky LS.

Toxicol Appl Pharmacol. 2001 Jan 15;170(2):93-103.

PMID:
11162773
16.

Erratum to "Expression of an estrogen receptor alpha variant protein in cell lines and tumors".

Fasco MJ, Keyomarsi K, Arcaro KF, Gierthy JF.

Mol Cell Endocrinol. 2000 Aug 30;166(2):155-69. No abstract available.

PMID:
10996434
17.

Expression of an estrogen receptor alpha variant protein in cell lines and tumors.

Fasco MJ, Keyomarsi K, Arcaro KF, Gierthy JF.

Mol Cell Endocrinol. 2000 Apr 25;162(1-2):167-80. Corrected and republished in: Mol Cell Endocrinol. 2000 Aug 30;166(2):156-69.

PMID:
10854710
18.

Analysis of amplified DNA molecules by capillary electrophoresis and laser induced fluorescence.

Fasco MJ.

Methods Mol Med. 1999;26:131-46. doi: 10.1385/0-89603-518-2:131.

PMID:
21340874
19.
20.
21.

Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells.

Spink DC, Spink BC, Cao JQ, DePasquale JA, Pentecost BT, Fasco MJ, Li Y, Sutter TR.

Carcinogenesis. 1998 Feb;19(2):291-8.

PMID:
9498279
22.

Inhibition of estrone sulfatase in human liver microsomes by quercetin and other flavonoids.

Huang Z, Fasco MJ, Kaminsky LS.

J Steroid Biochem Mol Biol. 1997 Sep-Oct;63(1-3):9-15.

PMID:
9449200
23.

The molecular epidemiology of lung cancer.

Spivack SD, Fasco MJ, Walker VE, Kaminsky LS.

Crit Rev Toxicol. 1997 Jul;27(4):319-65. Review.

PMID:
9263643
24.

Alternative splicing of CYP2D mRNA in human breast tissue.

Huang Z, Fasco MJ, Kaminsky LS.

Arch Biochem Biophys. 1997 Jul 1;343(1):101-8.

PMID:
9210651
25.

Comparisons of CYP2D messenger RNA splice variant profiles in human lung tumors and normal tissues.

Huang Z, Fasco MJ, Spivack S, Kaminsky LS.

Cancer Res. 1997 Jul 1;57(13):2589-92.

26.
27.

Regulation of cytochrome P4501A1 expression in rat small intestine.

Zhang QY, Wikoff J, Dunbar D, Fasco M, Kaminsky L.

Drug Metab Dispos. 1997 Jan;25(1):21-6.

PMID:
9010625
28.
29.

Expression of cytochromes P450 in human breast tissue and tumors.

Huang Z, Fasco MJ, Figge HL, Keyomarsi K, Kaminsky LS.

Drug Metab Dispos. 1996 Aug;24(8):899-905.

PMID:
8869826
30.

Optimization of Dnase I removal of contaminating DNA from RNA for use in quantitative RNA-PCR.

Huang Z, Fasco MJ, Kaminsky LS.

Biotechniques. 1996 Jun;20(6):1012-4, 1016, 1018-20.

31.

Cytochrome P450 mRNA induction: quantitation by RNA-polymerase chain reaction using capillary electrophoresis.

Fasco MJ, Treanor C, Kaminsky LS.

Methods Enzymol. 1996;272:401-12. No abstract available.

PMID:
8791799
32.

Human cytochromes P4501A1 and P4501A2: R-warfarin metabolism as a probe.

Zhang Z, Fasco MJ, Huang Z, Guengerich FP, Kaminsky LS.

Drug Metab Dispos. 1995 Dec;23(12):1339-46.

PMID:
8689941
33.

Determination of theophylline and its metabolites in rat liver microsomes and human urine by capillary electrophoresis.

Zhang ZY, Fasco MJ, Kaminsky LS.

J Chromatogr B Biomed Appl. 1995 Mar 10;665(1):201-8.

PMID:
7795792
34.

Quantitative RNA-polymerase chain reaction-DNA analysis by capillary electrophoresis and laser-induced fluorescence.

Fasco MJ, Treanor CP, Spivack S, Figge HL, Kaminsky LS.

Anal Biochem. 1995 Jan 1;224(1):140-7.

PMID:
7710061
35.

Rat small intestinal cytochromes P450 probed by warfarin metabolism.

Fasco MJ, Silkworth JB, Dunbar DA, Kaminsky LS.

Mol Pharmacol. 1993 Feb;43(2):226-33.

PMID:
8429825
36.

Small intestinal cytochromes P450.

Kaminsky LS, Fasco MJ.

Crit Rev Toxicol. 1991;21(6):407-22. Review.

PMID:
1801846
37.
38.

Comparative effects of cefoxitin and cefotetan on vitamin K metabolism.

Sieradzan RR, Bottner WA, Fasco MJ, Bertino JS Jr.

Antimicrob Agents Chemother. 1988 Sep;32(9):1446-9.

39.
40.

Evidence for a warfarin-sensitive serum factor that participates in factor X activation by Lewis lung tumor cells.

Fasco MJ, Wilson AC, Lincoln D, Gierthy J.

Int J Cancer. 1987 May 15;39(5):631-7.

PMID:
3570555
41.

Identification of vitamin K1 chromenol--a novel metabolite of vitamin K1 formed in vitro by a component in blood.

Fasco MJ, Wilson AC, Briggs RG, Gierthy JF.

Arch Biochem Biophys. 1987 Feb 1;252(2):501-6.

PMID:
3813548
42.

Vitamin-K-dependent proteins in microsomes of primary Lewis lung tumors.

Wilson AC, Fasco MJ.

Int J Cancer. 1986 Dec 15;38(6):877-82.

PMID:
3793264
44.

Metabolism of vitamin K and vitamin K 2,3-epoxide via interaction with a common disulfide.

Lee JJ, Fasco MJ.

Biochemistry. 1984 May 8;23(10):2246-52.

PMID:
6733086
45.

Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes.

Fasco MJ, Principe LM, Walsh WA, Friedman PA.

Biochemistry. 1983 Nov 22;22(24):5655-60.

PMID:
6652076
46.

Formation of hydroxyvitamin K by vitamin K epoxide reductase of warfarin-resistant rats.

Fasco MJ, Preusch PC, Hildebrandt E, Suttie JW.

J Biol Chem. 1983 Apr 10;258(7):4372-80.

47.

Evidence that warfarin anticoagulant action involves two distinct reductase activities.

Fasco MJ, Hildebrandt EF, Suttie JW.

J Biol Chem. 1982 Oct 10;257(19):11210-2.

48.
49.

Vitamin K1 hydroquinone formation catalyzed by DT-diaphorase.

Fasco MJ, Principe LM.

Biochem Biophys Res Commun. 1982 Jan 15;104(1):187-92. No abstract available.

PMID:
6803779
50.

Reappraisal of thromboplastin.

Ziegler FD, Rich SA, Fasco MJ, Russell C, Kelly JH.

Ann Clin Lab Sci. 1981 May-Jun;11(3):202-10. Review.

PMID:
7018366

Supplemental Content

Support Center